|
⚲
|
| Keyboard |
| Michael Dial | |
|---|---|
| Firm | |
| Address | 6 Davis Drive Suite 159 Durham, NC 27709 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Altis Biosystems Inc | 021-543110 | Director | 2.1 M of 2.2 M |
||
| Atsena Therapeutics Inc | 021-493532 | Director | 24.5 M of 32.0 M |
||
| Atsena Therapeutics Inc | 021-384201 | Director | 27.5 M of 55.0 M |
||
| Atsena Therapeutics Inc | 021-366568 | Director | 4.1 M of 8.1 M |
||
| Ribometrix Inc | 021-326066 | Director | 15.0 M of 30.0 M |
||
| Kinodyn Inc | 021-252561 | Executive Officer | 0.3 M of 0.3 M |
||
| Curoverse Inc | 021-202740 | Director | 1.7 M of 1.7 M |
||
| Hatteras Venture Advisors VII LLC | |||||
| Hatteras Opportunity Fund I LP | 021-472491 | Executive Officer | 26.0 M of 125.0 M |
32.6 M | |
| Hatteras Venture Partners VII LP | 021-472476 | Executive Officer | 135.1 M of 250.0 M |
175.8 M | |
| Hatteras Venture Advisors VI LLC | |||||
| Hatteras Venture Partners VI LP | 021-337301 | Executive Officer | 137.3 M of 250.0 M |
123.9 M | |